Geode Capital Management
OMGA

Geode Capital Management’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Geode Capital Management’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-230,833
Closed -$172K – 4541
2024
Q4 		$172K Hold
230,833
– – ﹤0.01% 3949
2024
Q3 		$282K Sell
230,833
-6,000
-3% -$9.55K ﹤0.01% 3788
2024
Q2 		$490K Sell
236,833
-263,671
-53% -$622K ﹤0.01% 3568
2024
Q1 		$1.83M Buy
500,504
+22,866
+5% +$87.7K ﹤0.01% 3141
2023
Q4 		$1.44M Buy
477,638
+19,056
+4% +$38.6K ﹤0.01% 3209
2023
Q3 		$986K Buy
458,582
+15,660
+4% +$62.6K ﹤0.01% 3325
2023
Q2 		$2.48M Buy
442,922
+261,379
+144% +$2.04M ﹤0.01% 3046
2023
Q1 		$1.09M Hold
181,543
– – ﹤0.01% 3307
2022
Q4 		$1.04M Sell
181,543
-362
-0.2% -$2.03K ﹤0.01% 3322
2022
Q3 		$985K Buy
181,905
+98,079
+117% +$497K ﹤0.01% 3397
2022
Q2 		$318K Sell
83,826
-189,070
-69% -$704K ﹤0.01% 4000
2022
Q1 		$1.7M Buy
272,896
+145,541
+114% +$1.49M ﹤0.01% 3339
2021
Q4 		$1.44M Buy
127,355
+55,459
+77% +$1.05M ﹤0.01% 3539
2021
Q3 		$1.35M Buy
+71,896
New +$1.38M ﹤0.01% 3530

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Geode Capital Management's OMGA Position: Q1 2025 in Review

Geode Capital Management sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 230,833 shares — an estimated $172K sold.

Geode Capital Management first reported a position in OMGA in Q3 2021 and held it in 14 quarters. The position peaked at $2.48M in Q2 2023. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Geode Capital Management reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Geode Capital Management sold 230,833 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $172K.
  • Geode Capital Management first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 14 quarters.
  • Geode Capital Management's Omega Therapeutics, Inc. Common Stock position peaked at $2.48M in Q2 2023.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.